Interpretable biomanufacturing process risk and sensitivity analyses for quality‐by‐design and stability control
暂无分享,去创建一个
Wei Xie | Bo Wang | Cheng Li | Jared Auclair | Dongming Xie | Jared R Auclair | D. Xie | Wei Xie | Bo Wang | Cheng Li
[1] L. Shapley. A Value for n-person Games , 1988 .
[2] Ilya M. Sobol,et al. Sensitivity Estimates for Nonlinear Mathematical Models , 1993 .
[3] Jon C. Helton,et al. Uncertainty and sensitivity analysis techniques for use in performance assessment for radioactive waste disposal , 1993 .
[4] Pauline M. Doran,et al. Bioprocess Engineering Principles , 1995 .
[5] Harvey M. Wagner,et al. Global Sensitivity Analysis , 1995, Oper. Res..
[6] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[7] Enrique F. Castillo,et al. Sensitivity analysis in discrete Bayesian networks , 1997, IEEE Trans. Syst. Man Cybern. Part A.
[8] H. Rabitz,et al. General foundations of high‐dimensional model representations , 1999 .
[9] A. Owen,et al. A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae) , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development , Manufacturing , and Quality Assurance , 2004 .
[11] Yuhong Zhou,et al. A decisional-support tool to model the impact of regulatory compliance activities in the biomanufacturing industry , 2004, Comput. Chem. Eng..
[12] Yunfeng Li,et al. Prediction of Key State Variables using Support Vector Machines in Bioprocesses , 2006 .
[13] Matthew C Coleman,et al. Retrospective optimization of time‐dependent fermentation control strategies using time‐independent historical data , 2006, Biotechnology and bioengineering.
[14] Silja Renooij,et al. Sensitivity Analysis of Probabilistic Networks , 2007 .
[15] G. Walsh. Pharmaceutical Biotechnology: Concepts and Applications , 2007 .
[16] L. Papageorgiou,et al. Multiobjective Long‐Term Planning of Biopharmaceutical Manufacturing Facilities , 2007, Biotechnology progress.
[17] J. Engelbrecht,et al. Acetone to MIBK process optimization through multidisciplinary chemometrics and in-line NIR spectroscopy , 2008 .
[18] Xiaobo Zhou,et al. Global Sensitivity Analysis , 2017, Encyclopedia of GIS.
[19] Daniel Gómez,et al. Polynomial calculation of the Shapley value based on sampling , 2009, Comput. Oper. Res..
[20] Nir Friedman,et al. Probabilistic Graphical Models - Principles and Techniques , 2009 .
[21] L. Stragevitch,et al. Prediction of properties of diesel/biodiesel blends by infrared spectroscopy and multivariate calibration , 2010 .
[22] A S Rathore,et al. Process analytical technology (PAT) for biopharmaceutical products , 2010, Analytical and bioanalytical chemistry.
[23] Z Zi,et al. Sensitivity analysis approaches applied to systems biology models. , 2011, IET systems biology.
[24] Yao Zhao,et al. Planning for demand failure: A dynamic lot size model for clinical trial supply chains , 2011, Eur. J. Oper. Res..
[25] C. Herwig,et al. Efficient feeding profile optimization for recombinant protein production using physiological information , 2012, Bioprocess and Biosystems Engineering.
[26] Chouaib Chakour,et al. New Adaptive Moving Window PCA for Process Monitoring , 2012 .
[27] Heikki Huttunen,et al. Bioprocess data mining using regularized regression and random forests , 2013, BMC Systems Biology.
[28] Marie-Lise Moullec,et al. Toward System Architecture Generation and Performances Assessment Under Uncertainty Using Bayesian Networks , 2013 .
[29] Minqiang Li,et al. A security risk analysis model for information systems: Causal relationships of risk factors and vulnerability propagation analysis , 2014, Inf. Sci..
[30] Jun Yang,et al. Generalized moment-independent importance measures based on Minkowski distance , 2014, Eur. J. Oper. Res..
[31] Cassandra Telenko,et al. Probabilistic Graphical Modeling of Use Stage Energy Consumption: A Lightweight Vehicle Example , 2014 .
[32] Eric S. Langer,et al. Single‐use technologies in biopharmaceutical manufacturing: A 10‐year review of trends and the future , 2014 .
[33] Art B. Owen,et al. Sobol' Indices and Shapley Value , 2014, SIAM/ASA J. Uncertain. Quantification.
[34] Ulf Schrader,et al. From Science to Operations Questions , Choices and Strategies for Success in Biopharma , 2014 .
[35] Zuo-Jun Max Shen,et al. An automated planning engine for biopharmaceutical production , 2014, Eur. J. Oper. Res..
[36] Solomon Tesfamariam,et al. Evaluating risk of water mains failure using a Bayesian belief network model , 2015, Eur. J. Oper. Res..
[37] Niranjan S. Kulkarni. A modular approach for modeling active pharmaceutical ingredient manufacturing plant: A case study , 2015, 2015 Winter Simulation Conference (WSC).
[38] Philip M. Kaminsky,et al. Analytical models for biopharmaceutical operations and supply chain management: a survey of research literature , 2015 .
[39] Richard D. Braatz,et al. Elastic net with Monte Carlo sampling for data-based modeling in biopharmaceutical manufacturing facilities , 2015, Comput. Chem. Eng..
[40] Barry L. Nelson,et al. Shapley Effects for Global Sensitivity Analysis: Theory and Computation , 2016, SIAM/ASA J. Uncertain. Quantification.
[41] Ananth Krishnamurthy,et al. Optimal condition-based harvesting policies for biomanufacturing operations with failure risks , 2016 .
[42] Emanuele Borgonovo,et al. Sensitivity analysis: A review of recent advances , 2016, Eur. J. Oper. Res..
[43] René Holm,et al. Q8(R2): Pharmaceutical Development , 2017 .
[44] Scott Lundberg,et al. A Unified Approach to Interpreting Model Predictions , 2017, NIPS.
[45] Venkat Venkatasubramanian,et al. Neural Network to Understand Process Capability and Process Intermediates Acceptance Criteria in Monoclonal Antibody Production Process , 2017, Journal of Pharmaceutical Innovation.
[46] Kok Siong Ang,et al. Kinetic Modeling of Mammalian Cell Culture Bioprocessing: The Quest to Advance Biomanufacturing , 2018, Biotechnology journal.
[47] Richard D. Braatz,et al. Sparse canonical variate analysis approach for process monitoring , 2018, Journal of Process Control.
[48] Xun Xu,et al. A Knowledge Management System to Support Design for Additive Manufacturing Using Bayesian Networks , 2018 .
[49] Massimo Morbidelli,et al. Sequential Multivariate Cell Culture Modeling at Multiple Scales Supports Systematic Shaping of a Monoclonal Antibody Toward a Quality Target. , 2018, Biotechnology journal.
[50] Ananth Krishnamurthy,et al. Performance Guarantees and Optimal Purification Decisions for Engineered Proteins , 2017, Oper. Res..
[51] Christoph Herwig,et al. Comparison of data science workflows for root cause analysis of bioprocesses , 2018, Bioprocess and Biosystems Engineering.
[52] Manoj Kumar Tiwari,et al. Bayesian network modelling for supply chain risk propagation , 2018, Int. J. Prod. Res..
[53] Christoph Herwig,et al. Data science tools and applications on the way to Pharma 4.0. , 2019, Drug discovery today.
[54] Sarfaraz K. Niazi. Pharmaceutical Development , 2019, Handbook of Pharmaceutical Manufacturing Formulations.
[55] Ronald Rader,et al. Single‐Use Technologies in Biopharmaceutical Manufacturing , 2019 .
[56] Ananth Krishnamurthy,et al. Managing Trade-offs in Protein Manufacturing: How Much to Waste? , 2020, Manuf. Serv. Oper. Manag..